People · Operator
Named in public records as an officer, director or promoter · active 2009–2009 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Sequel Pharmaceuticals Inc | — | Pharmaceuticals | Seed | $5.4M | $38.0M | 2009 |
Mark Murgerditchian at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark Murgerditchian on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Nina Kjellson | 1 | 11 |
| David Lowe | 1 | 5 |
| Stuart J.M. Collinson | 1 | 4 |
| Joseph Turner | 1 | 4 |
| Eckard Weber | 1 | 3 |
| Randall Woods | 1 | 2 |
| Howard C. Dittrich | 1 | 2 |
| Daniel K. Turner, III | 1 | 2 |
| Paul K. Chamberlain | 1 | 1 |
| Brian K. Farmer | 1 | 1 |
| Eckard K. Weber | 1 | 1 |
| Nina K. Kjellson | 1 | 1 |
| Joseph K. Turner | 1 | 1 |
| David K. Lowe | 1 | 1 |
| Mark C. Murgerditchian | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.